Sparrow Pharmaceuticals, Inc. — Form D
Sparrow Pharmaceuticals, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-12. The offering totals $15.3M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-04-12
- Form: D
- Accession: 0001786949-24-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.3M
- Amount sold: $10.0M
- Remaining: $5.3M
- Investors: 4
- Date of first sale: 2024-04-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-510516
Issuer
- Name: Sparrow Pharmaceuticals, Inc.
- CIK: 0001786949
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1050 Southwest 6th Street, PORTLAND, OR, 97204
- Phone: 6174650328
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| DAVID KATZ | Executive Officer | Dover, DE |
| Jonathan Root | Director | Aliso Viejo, CA |
| Niall O'Donnell | Director | St. Louis, MO |
| Zach Scheiner | Director | Boston, MA |
| Klaus Veitinger | Director | Chanhassen, MN |
| Nanna L?neborg | Director | Portland, OR |
| Peter Thompson | Director | Chanhassen, MN |
| Robert Jacks | Director | Portland, OR |
| Robert Jacks | Executive Officer | Portland, OR |
| David Aaron Katz | Director | Portland, OR |
| David Aaron Katz | Executive Officer | Portland, OR |
Other filings by this issuer (4)
More